IFNB1 and breast carcinoma: Together, results using IFNβ-treated T47D overexpressing ISG15, MDA/LV-control shRNA constitutively overexpressing ISG15, and ZR/control shRNA breast cancer cells constitutively overexpressing ISG15 reveal that ISG15 increases MHC class I surface expression and antigen presentation in breast cancer cells.